Skip to main content


Figure 1 | BMC Pharmacology

Figure 1

From: Interaction between bradykinin and urodilatin - a possible mechanism of clinical relevance

Figure 1

Effects of natriuretic peptides and cGMP signaling pathway on bradykinin (BK) action. BK – bradykinin; NPPB – inhibitor of Ca2+-dependent Cl- channels; ANP – atrial natriuretic peptide; URO – urodilatin; BNP – brain natriuretic peptide; CNP – C-type natiuretic peptide; KT5823 – inhibitor protein kinase G. Number of experiments are given in brackets. * p<0.05 compared to depolarizations caused by bradykinin alone

Back to article page